Cancer is a disease that is caused by the uncontrolled growth of abnormal cells in the body. It is one of the leading causes of death worldwide, with millions of people being diagnosed with the disease each year. Some of the major factors contributing to cancer cases include tobacco use, exposure to harmful gases, poor diet, physical inability, infectious agents, and others.  

Request Sample PDF here @ https://univdatos.com/report/cancer-treatment-drugs-market/get-a-free-sample-form.php?product_id=36487

The surge in the incidence of cancer has surged the demand for cancer treatment drugs in the past few years. According to World Health Organization, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020 globally. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers.

Figure 1: Worldwide Cancer Incidence’2020

The development of cancer therapies has been an active area of research for many years, resulting in a range of treatment options that can be used to manage and treat cancer. These therapies include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and hormone therapy, among others. Targeted therapy is a type of cancer treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. Unlike chemotherapy, which attacks all rapidly dividing cells, including healthy ones, targeted therapy is designed to specifically target cancer cells and spare healthy cells. Currently, the majority of research is being focused on the development of new targeted therapies.

Apart from targeted therapy, immunotherapy has also gained considerable momentum among pharmaceutical giants. Immunotherapy is a type of cancer treatment that harnesses the power of the immune system to recognize approaches including therapeutic antibodies, immune checkpoint inhibitors, vaccines, chimeric antigen receptor T-cell therapy, and others which have shown promising responses in the management of several cancers.

Ask for Customization @ https://univdatos.com/report/cancer-treatment-drugs-market/get-a-free-sample-form.php?product_id=36487

The encouraging response has propelled further research and development activities among pharmaceutical giants design more efficient and targeted cancer drugs. The major companies in cancer research including Sanofi, Pfizer, Amgen, Roche, and others have actively invested in cancer research. For instance, in July 2021, Amgen acquired  Teneobio, a privately held, clinical-stage biotechnology company developing a new class of biologics called Human Heavy-Chain Antibodies. The acquisition includes Teneobio's proprietary bispecific and multispecific antibody technologies, which will enable significant acceleration and efficiency in the discovery and development of new molecules that have the potential to treat cancer and other chronic diseases.

                Figure 2: Cancer Treatment drugs approval by U.S. FDA, 2016-2021

Get more information , Please Visit us : https://univdatos.com/report/cancer-treatment-drugs-market/

RECENT FDA DRUG APPROVALS

CONCLUSION

The demand for cancer treatment drugs is growing at high rates in the past few years, with several big players adopting strategic alliances with emerging small start-ups with an aim to launch novel cancer therapies. Further, investments in cancer research have also increased over the past few years and so are the adoption rate. Patients in the US are the highest adopter of novel cancer therapies followed by developed European countries including the UK, Denmark, and France. Developing countries such as India, China, and other Middle East countries have witnessed increased adoption of cancer treatment drugs over the past few years, but at a slow pace, however, the demand for cancer therapies is expected to increase by 2022, owing to the surge in the prevalence of cancer and rising awareness among the individuals regarding the availability of cancer treatment drugs. Contact Universal Data Solutions, a rapidly growing dynamic market research firm led by a core of dedicated professionals for further information. According to the Universal Data Solutions analysis, the development of advanced technologies would massively transform the global scenario of cancer treatment drugs and as per their “Cancer Treatment Drugs Market” report, the global market was valued at USD 150 billion in 2021, growing at a CAGR of 10% during the forecast period from 2022 - 2028 to reach USD XX billion by 2028.